Mutated BRAF non-V600E tumours are associated with younger age, lower degree of cellular differentiation, less frequency mucinous histology, microsatellite stability, left-sided disease and a less aggressive evolution of cancer than patients with mutated BRAF V600E or wild-type BRAF tumours. This evidence concerns the gene BRAF and neoplasm.